Humacyte (HUMA) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Humacyte (HUMA) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Humacyte |
267.09 Mn |
218.55 Mn |
-1.54 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
7.63% |
| Dec 31, 2025 |
-26.56% |
| Sep 30, 2025 |
15.99% |
| Jun 30, 2025 |
-23.11% |
| Mar 31, 2025 |
14.18% |
| Dec 31, 2024 |
6.31% |
| Sep 30, 2024 |
-3.44% |
| Jun 30, 2024 |
-12.21% |
| Mar 31, 2024 |
-2.23% |
| Dec 31, 2023 |
-8.29% |
| Sep 30, 2023 |
8.33% |
| Jun 30, 2023 |
-18.59% |
| Mar 31, 2023 |
-8.08% |
| Dec 31, 2022 |
13.26% |
| Sep 30, 2022 |
-22.99% |
| Jun 30, 2022 |
14.88% |
| Mar 31, 2022 |
-0.66% |
| Dec 31, 2021 |
-5.84% |
| Sep 30, 2021 |
-6.16% |
| Jun 30, 2021 |
-0.89% |
